No intervention involved / Autism Spectrum Disorder / Somatic Symptom Disorder · Observational Study
ClinicalTrials.gov · August 17, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is a planned observational study integrating retrospective clinical data from 2014–2023 to examine associations between autism spectrum traits and somatic symptoms, using multiple validated questionnaires. No results are reported in this registry record; the study is active but not recruiting.
Observational. Autism Spectrum Disorder, Somatic Symptom Disorder; age from 15 Years; to 70 Years; accepts healthy volunteers. Intervention: ASD; Clinical; Control. n = 600. 1 site: Taiwan.
This is a planned observational study integrating retrospective clinical data from 2014–2023 to examine associations between autism spectrum traits and somatic symptoms, using multiple validated questionnaires. No results are reported in this registry record; the study is active but not recruiting.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
This is a clinical trial registry record describing a planned observational study with no results yet posted; it documents study design and data collection parameters only, not outcomes.
As stated by the source record.
Quoted from the source exactly as published.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no key findings. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT05886361). This is a study registration, not published results. Lead sponsor: National Taiwan University Hospital. Recruitment status: ACTIVE_NOT_RECRUITING. Study type: OBSERVATIONAL. Enrollment: 600 participants (ESTIMATED). Conditions: Autism Spectrum Disorder, Somatic Symptom Disorder. Interventions: OTHER: No intervention involved. Primary outcome measures: Patient health questionnaire-15, PHQ-15 , Time of the original assessment (data collected retrospectively from January 1, 2014 to March 21, 2023); Health assessment questionnaire, HAQ , Time of the original assessment (data collected retrospectively from January 1, 2014 to March 21, 2023); Beck depression inventory, BDI , Time of the original assessment (data collected retrospectively from January 1, 2014 to March 21, 2023); Beck anxiety inventory , Time of the original assessment (data collected retrospectively from January 1, 2014 to March 21, 2023); Tridimensional Personality Questionnaire (TPQ) , Time of the original assessment (data collected retrospectively from January 1, 2014 to March 21, 2023); WHO Quality of Life-BREF (WHOQOL-BREF) , Time of the original assessment (data collected retrospectively from January 1, 2014 to March 21, 2023); Sensory profile , Time of the original assessment (data collected retrospectively from January 1, 2014 to March 21, 2023); Social responsiveness scale (SRS) , Time of the original assessment (data collected retrospectively from January 1, 2014 to March 21, 2023); Autism Spectrum Quotient (AQ) , Time of the original assessment (data collected retrospectively from January 1, 2014 to March 21, 2023); Empathy Quotient (EQ) , Time of the original assessment (data collected retrospectively from January 1, 2014 to March 21, 2023). Brief summary: Autistic patients have higher rates of co-morbid somatic symptoms. Thus, compared to the general population, they experience more health-related concerns, such as autoimmune disease, gastrointestinal disease, cardiovascular disease, and autonomic disorders. On average, an autistic patient's life span is 16 years shorter than that of a non-autistic patient. Furthermore, autistic patients are often unable to convey or communicate their somatic symptoms in a clear and comprehensive manner. This leads to a lack of proper health care provided in a timely manner.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.